The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells
Top Cited Papers
- 5 March 2006
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 38 (4), 431-440
- https://doi.org/10.1038/ng1760
Abstract
Oct4 and Nanog are transcription factors required to maintain the pluripotency and self-renewal of embryonic stem (ES) cells. Using the chromatin immunoprecipitation paired-end ditags method, we mapped the binding sites of these factors in the mouse ES cell genome. We identified 1,083 and 3,006 high-confidence binding sites for Oct4 and Nanog, respectively. Comparative location analyses indicated that Oct4 and Nanog overlap substantially in their targets, and they are bound to genes in different configurations. Using de novo motif discovery algorithms, we defined the cis-acting elements mediating their respective binding to genomic sites. By integrating RNA interference–mediated depletion of Oct4 and Nanog with microarray expression profiling, we demonstrated that these factors can activate or suppress transcription. We further showed that common core downstream targets are important to keep ES cells from differentiating. The emerging picture is one in which Oct4 and Nanog control a cascade of pathways that are intricately connected to govern pluripotency, self-renewal, genome surveillance and cell fate determination.Keywords
This publication has 86 references indexed in Scilit:
- From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancerCell Research, 2011
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancerNature Medicine, 2009
- Recent Trends in Breast Cancer Among Younger Women in the United StatesJNCI Journal of the National Cancer Institute, 2008
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005
- Gene identification signature (GIS) analysis for transcriptome characterization and genome annotationNature Methods, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Self-renewal of teratocarcinoma and embryonic stem cellsOncogene, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- New type of POU domain in germ line-specific protein Oct-4Nature, 1990